- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06447571
Trunk Rehabilitation Compared to Core Stability in Patients With Multiple Sclerosis
The Effect of Trunk Rehabilitation Compared to Core Stability on Balance, Gait, Falls and Community Mobility in Patients With Multiple Sclerosis
BACKGROUND Balance, gait, community mobility, and risk of falls are often associated with trunk impairment among people with Multiple Sclerosis (PwMS). Consequently, there is a pressing need for interventions addressing these concerns and exploring the potential effects of trunk rehabilitation.
LONG-TERM GOAL Offering guidance for effective plan selection, potentially included in rehabilitation guidelines for PwMS.
HYPOTHESIS Trunk exercises performed in multiplanar movement on unstable surfaces incorporated with dual-tasks (DT) could improve the functional outcomes more than standard one-plane core stability exercises.
SPECIFIC AIMS Investigating the effectiveness of trunk rehabilitation in PwMS and determining the optimal intervention strategy.
METHODS 50 PwMS randomly assigned into two groups. Trunk Group received trunk exercises on unstable surfaces with DT training, while the Core Group underwent standard one-plane core stability exercises on stable surfaces without DT. Additionally, both received conventional treatment. Primary outcome was the trunk impairment scale (TIS). Secondary outcomes included the Berg balance scale (BBS), Timed Up and Go (TUG), Modified Falls Efficacy (FES), Modified Fatigue Impact Scale (MFIS), Hospital Anxiety and Depression Scale (HADS), and Reintegration to Normal Living Index (RNLI).
SIGNIFICANCE Enhancing our understanding of trunk exercises' benefits and providing valuable guidance to clinicians for choosing the optimal treatment plan.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Jeddah, Saudi Arabia, 21589
- King Abdulaziz University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinically diagnosed with MS (McDonald's criteria)
- Able to walk 5 meters without assistance.
- No relapse in the past 2 months.
Exclusion Criteria:
- Recent surgery.
- Cognitive or psychological dysfunctions.
- Diagnosis of any other systematic disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Trunk Group
Trunk exercises in multiplanar movement coupled with dual tasks on unstable surfaces.
|
Activating and strengthening the trunk muscles.
|
|
Active Comparator: Core stability Group
Standard Core stability exercises carried in one plane on stable surfaces without dual tasks.
|
Standard core stability fucus on lower trunk.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trunk Impairment Scale (TIS)
Time Frame: Baseline, 6 weeks, 1 month follow up.
|
evaluates motor impairment of the trunk by assessing static and dynamic sitting balance and coordination of trunk movement.
The total scores range between 0 for a minimal performance to 23 for a maximum performance.
|
Baseline, 6 weeks, 1 month follow up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale (BBS)
Time Frame: Baseline, 6 weeks, 1 month follow up.
|
standardized assessment tool utilized to objectively evaluate an individual's ability to maintain balance during specific tasks.
The total scores range between 0 for a minimal performance to 56 for a maximum performance.
|
Baseline, 6 weeks, 1 month follow up.
|
|
Timed Up and Go (TUG)
Time Frame: Baseline, 6 weeks, 1 month follow up.
|
used to evaluate functional mobility.
|
Baseline, 6 weeks, 1 month follow up.
|
|
Modified Falls Efficacy Scale (MFES)
Time Frame: Baseline, 6 weeks, 1 month follow up.
|
modified and expanded version of the Falls Efficacy Scale (FES), which assesses the fear of falling.
The total scores range between 0 reflecting less confidence and more fear of falling to 140 for more confidence and less fear of falling.
|
Baseline, 6 weeks, 1 month follow up.
|
|
Modified Fatigue Impact Scale (MFIS)
Time Frame: Baseline, 6 weeks, 1 month follow up.
|
evaluates the effects of fatigue on cognitive, psychosocial, and physical functioning.
The total scores range from 0 reflecting less impact of fatigue to 84 for greater impact of fatigue.
|
Baseline, 6 weeks, 1 month follow up.
|
|
Reintegration to Normal Living Index (RNLI)
Time Frame: Baseline, 6 weeks, 1 month follow up.
|
to assess community mobility.
focus on measuring the extent of reintegration into regular social activities among individuals affected by disease.
Scores range from 0 to 110, a lower score indicates minimal integration, and higher scores indicate better integration.
A total score out of 110 points is proportionally converted to create a score out of 100.
|
Baseline, 6 weeks, 1 month follow up.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Majed M Albadi, PhD, King Abdulaziz University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Trunk Rehabilitation in MS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Trunk Rehabilitation
-
Saglik Bilimleri UniversitesiRecruitingAdolescent | Exercise | Cerebral Palsy (CP) | TrunkTurkey
-
Union de Gestion des Etablissements des Caisses...CompletedCerebral Palsy, SpasticFrance
-
Istanbul Medipol University HospitalThe Scientific and Technological Research Council of TurkeyCompletedMuscular Atrophy, SpinalTurkey
-
Cairo UniversityUnknownValvular Heart DiseaseEgypt
-
Medipol UniversityRecruitingScoliosis | Exercise | Pulmonary Rehabilitation | Spinal Muscular Atrophy Type I | Chest Deformities | Spinal OrthosisTurkey
-
Riphah International UniversityNot yet recruitingKnee OsteoarthritisPakistan
-
Ahi Evran University Education and Research HospitalRecruitingCore Exercises Training | Rotator Cuff Injury (RCI)Turkey (Türkiye)
-
Pusan National University Yangsan HospitalCompletedStrokeKorea, Republic of
-
University of LahoreRecruitingParkinson s DiseasePakistan
-
University of ValenciaCompleted